Use of an Electronic Medical Record (EMR) to identify glycemic intensification strategies in type 2 diabetes

Journal of Diabetes Science and Technology

Volumn 9, Issue 3, 2015, Pages 593-601

  Korytkowski, Mary T ^a   Brooks, Maria ^b   Lombardero, Manuel ^b   De Almeida, Dilhari ^c   Kanter, Justin ^d   Magaji, Vasudev ^e   Orchard, Trevor ^b   Siminerio, Linda ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

Electronic health records; Hospital information systems; Hypoglycemic agents; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRESCRIPTION; RACE DIFFERENCE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; AGED; AGONISTS; BLOOD; BLOOD PRESSURE; COMPLICATION; DIABETES MELLITUS, TYPE 2; ELECTRONIC HEALTH RECORD; GLUCOSE BLOOD LEVEL; MEDICATION THERAPY MANAGEMENT; METABOLISM; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; RETROSPECTIVE STUDY;

AGED; BIOMARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; ELECTRONIC HEALTH RECORDS; FEMALE; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 84960331112     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296814564183     Document Type: Article

References (35)

1. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35:1364-1379.
2. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2014;37:S14-S80.
3. Garber AJ, Abrahamson MJ, Barzilay JI, et al. AACE comprehensive diabetes management algorithm 2013. Endocr Pract. 2013;19:327-336.
4. Qaseem A, Humphrey LL, Sweet DE, et al. Oral pharmaco-logic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2012;156:218-231.
5. Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults. Diabetes Care. 2012;35:1-15.
6. Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med. 2011;154:554-559.
7. Davidson MB. How our current medical care system fails people with diabetes: lack of timely, appropriate clinical decisions. Diabetes Care. 2009;32:370-372.
8. Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial. Ann Intern Med. 2005;143:559-569.
9. Joshi PH, Kalyani RR, Blumenthal RS, Donner TW. Cardiovascular effects of noninsulin, glucose-lowering agents: need for more outcomes data. Am J Cardiol. 2012;110: 32B-42B.
10. Reed M, Huang J, Graetz I, Brand R, Hsu J, Fireman B, Jaffe M. Outpatient electronic health records and the clinical care and outcomes of patients with diabetes mellitus. Ann Intern Med. 2012;157:482-489.
11. The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) is a long-term study of different treatments for type 2 diabetes. 2014. Available at: http://www.nih.gov/news/health/jun2013/niddk-2003.htm.
12. Brownstein JS, Murphy SN, Goldfine AB, et al. Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records. Diabetes Care. 2010;33:526-531.
13. Cimino JJ. Improving the electronic health record-are clinicians getting what they wished for? JAMA. 2013;309:991-992.
14. Zgibor JC, Orchard TJ, Saul M, et al. Developing and validating a diabetes database in a large health system. Diabetes Res Clin Pract. 2007;75:313-319.
15. Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care. 2004;27:1535-1540.
16. Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006;29:1963-1972.
17. Davis J, Chavez B, Juarez DT. Adjustments to diabetes medications in response to increases in hemoglobin a1c: an epide-miologic study. Ann Pharmacother. 2014;48:41-47.
18. Lovshin JA, Zinman B. Diabetes: Clinical inertia-a barrier to effective management of T2DM. Nat Rev Endocrinol. 2013;9:635-636.
19. Currie CJ, Peters JR, Tynan A, et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010;375:481-489.
20. Chalmers J, Cooper ME. UKPDS and the legacy effect. N Engl J Med. 2008;359:1618-1620.
21. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577-1589.
22. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-412.
23. Horton ES, Silberman C, Davis KL, Berria R. Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort database. Diabetes Care. 2010;33: 1759-1765.
24. Morgan CL, Poole CD, Evans M, Barnett AH, Jenkins-Jones S, Currie CJ. What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes. J Clin Endocrinol Metab. 2012;97:4605-4612.
25. Pawaskar M, Li Q, Hoogwerf BJ, et al. Metabolic outcomes of matched patient populations initiating exenatide BID vs. insulin glargine in an ambulatory care setting. Diabetes Obes Metab. 2012;14:626-633.
26. Zhang Q, Rajagopalan S, Mavros P, et al. Differences in baseline characteristics between patients prescribed sitagliptin versus exenatide based on a US electronic medical record database. Adv Ther. 2010;27:223-232.
27. Chen S-Y, Siu K, Kovacs B, et al. Clinical and economic outcomes associated with National Kidney Foundation guideline-concordant oral antidiabetic drug treatment among type 2 diabetes patients with chronic kidney disease. Curr Med Res Opin. 2012;28:493-501.
28. Grant RW, Buse JB, Meigs JB, University Health System Consortium Diabetes Benchmarking Project T. Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabetes Care. 2005;28:337-442.
29. Grant RW, Wexler DJ, Watson AJ, et al. How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists. Diabetes Care. 2007;30:1448-1453.
30. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301:1565-1572.
31. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2006;64:277-281.
32. Turchin A, Kohane IS, Pendergrass ML. Identification of patients with diabetes from the text of physician notes in the electronic medical record. Diabetes Care. 2005;28:1794-1795.
33. Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pendergrass ML. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009;32:1153-1157.
34. Ekedahl A, Brosius H, Jonsson J, Karlsson H, Yngvesson M. Discrepancies between the electronic medical record, the prescriptions in the Swedish national prescription repository and the current medication reported by patients. Pharmacoepidemiol Drug Saf. 2011;20:1177-1183.
35. Yasnoff WA, Sweeney L, Shortliffe EH. Putting health IT on the path to success. JAMA. 2013;309:989-990.